BiliBuddy vs NeoFast Calc
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
BiliBuddy
This app helps healthcare professionals determine the need for phototherapy or exchange therapy in newborns based on their age, bilirubin levels, and risk factors. It utilizes the latest American Academy of Pediatrics guidelines and displays results on interactive nomograms. The app also tracks infant data and provides links to relevant research.
- Calculates phototherapy threshold
- Displays on nomograms
- Calculates infant age
- Views risk factors
- Supports US and SI units
- Tracks bilirubin measures
Read full descriptionHide full description
BiliBuddy supports clinicians assessing neonatal jaundice in infants born at 35 weeks of gestation or later. Use Quick Check to compare a total serum bilirubin reading with American Academy of Pediatrics (AAP) 2022 phototherapy, escalation-of-care, and exchange-transfusion thresholds. Enter age in hours, gestation, and additional neurotoxicity risk factors. View the result and threshold charts in mg/dL or µmol/L. Track infants locally to review reading history, plot trends, and calculate the rate of rise. A date-and-time calculator helps determine age at measurement. Share a text result summary using the device's share sheet. The 2022 guideline is selected by default. An optional legacy AAP 2004 pathway is available in Settings, with its supported chart range clearly identified. Reference material and links to source guidelines are included. Clinical entries are stored on the device. Usage analytics is optional and off by default. Advertising and crash diagnostics use third-party services described in the in-app Privacy Notice. An in-app purchase removes ads, and Restore Purchases restores an eligible prior purchase. For clinician use. BiliBuddy does not replace clinical judgment, clinical assessment, or consultation of the source guideline. It is not an electronic health record. Do not use outside the supported age and gestation ranges.
NeoFast Calc
This medical reference tool simplifies daily tasks for healthcare professionals caring for newborns and children. It provides evidence-based prescribing assistance, drug interaction information, and extensive data on over 990 drug presentations.
- Neonatal and pediatric prescribing assistance
- Drug interaction and antagonist information
- Adverse reaction and brand name details
- Dose adjustment for renal/hepatic impairment
- Extensive drug presentation database
- Bibliographic references
Read full descriptionHide full description
An intuitive tool that aims to make the daily routine of all healthcare professionals who care for children and newborns easier. This application is based on several sources from national and international literature to assist in prescribing according to the dose stipulated by the neonatologist. In addition, it has a range of additional information on drug interactions, antagonists (in cases of poisoning or overdose), adverse reactions, international brands names, stability and conservation, dose adjustment in renal and hepatic impairment, general guidelines, etc. It also has more than 990 drug presentations and more than 160 worldwide bibliographic references. Therefore, it is a tool that ensures safety and agility on medical duty. Privacy Policy (EULA): https://neofastapp.com/privacy-terms/ Terms of use: https://neofastapp.com/privacy-terms/
Screenshots
Verdict
The clearest difference is ads: NeoFast Calc at none against BiliBuddy's shown. On price, review sentiment, update cadence and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. BiliBuddy sells 1 one-off in-app purchase and NeoFast Calc sells 2 in-app purchases, starting at $5.99 per month. Whichever you choose, the download price is not the number that matters.
BiliBuddy ships an update every 4 weeks, NeoFast Calc every 2 weeks. The most recent releases landed on November 2, 2026 and November 8, 2026 respectively.
| Parameter | BiliBuddy | NeoFast Calc |
|---|---|---|
| Price | Free | Free |
| Rating | 4.9 (258 ratings) — better | — |
| Positive reviews | 84.6% of reviews — better | 80.0% of reviews |
| Number of ratings | 258 — better | — |
| Update frequency | Every 4 weeks | Every 2 weeks — better |
| Ads | Yes | No — better |
| In-app purchases | Yes | Yes |
| Monetization | Free with in-app purchases | Freemium |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.1 — better | 15.6 |
| Further details — not scored | ||
| Size | 30 MB | 195 MB |
| Age rating | 17+ | 17+ |
| Developer | Covenant Data Systems, LLC | Ponto Direto Tech Ltda |
Customer experience
BiliBuddy
NeoFast Calc
Bugs and requests
BiliBuddy
Reported bugs
4 issues- Video/audio ads won't shut off
- App crashes
- Text boxes sometimes don't respond
- Link to further information doesn't work
Requested features
3 requests- Add or manage hours of phototherapy treatment
- Make scrolling between risk levels more obvious (e.g., more dots)
- Display low, intermediate, and high intermediate risk zones
NeoFast Calc
Not enough reviews yet to summarise bugs or requests.
In-app purchases
BiliBuddy
- Remove Ads$6.99
NeoFast Calc
- NeoFast® - Monthly Plan1 Month trial$5.991 Month
- NeoFast® - Yearly Plan1 Month trial$59.991 Year
Questions
Is BiliBuddy free?
Is NeoFast Calc free?
Do BiliBuddy or NeoFast Calc have ads?
Which is updated more often, BiliBuddy or NeoFast Calc?
Other comparisons
